Are you over 18 and want to see adult content?
More Annotations
A complete backup of www.cna.com.tw/news/firstnews/202002250020.aspx
Are you over 18 and want to see adult content?
A complete backup of www.livehindustan.com/entertainment/story-indian-idol-11-finale-live-update-sunny-hindustani-rohit-raut-adr
Are you over 18 and want to see adult content?
A complete backup of www.bbc.co.uk/sport/football/51532949
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of mastertungacupuncture.org
Are you over 18 and want to see adult content?
A complete backup of blackbird-drum.squarespace.com
Are you over 18 and want to see adult content?
A complete backup of xdlatino.blogspot.com
Are you over 18 and want to see adult content?
Text
ANNUAL REPORTS
Annual Report 2020 Remaining strong, resilient and agile. Family-owned since being established in 1983, Octapharma is a global healthcare company reaching hundreds of thousands of patients every year. CAREERS - OCTAPHARMA Learning and development. Each year, we recruit for our corporate trainee programme several young professionals and over 100 colleagues pass through our management training programmes. Octapharma also offers several online learning programmes. Check what we offer at aglobal level.
OCTANATE® - OCTAPHARMA Human plasma-derived coagulation factor VIII concentrate, naturally stabilised with von Willebrand factor (VWF) EUROPEAN AND GERMAN AUTHORITIES APPROVE OCTAGAM® 10% FOR Octapharma announced today that octagam® 10%, a human plasma-derived intravenous immunoglobulin (IVIg), has recently been granted approval in the European Union (EU) as an immunomodulatory therapy for adults with dermatomyositis. Following the EU approval, octagam 10%® received national approval in Germany on May 11, 2 LEADERSHIP - OCTAPHARMA Frederic Marguerre. Shareholders’ Representative, President Octapharma Plasma Inc. USA. Tobias Marguerre. Managing Director, Octapharma Nordic AB OCTAPLAS® / OCTAPLASLG® octaplas® and octaplasLG® are available in 200 ml bags. ALBUNORM® - OCTAPHARMA What can we help you find? About us . About us . Who we areDONOR360
Donor360
OCTAPHARMA SLOVAKIA
Octapharma develops and produces high-quality human proteins from human plasma and human cell lines. Learn more about our products to treat rare diseases and other coagulopathies and bleeding disorders. Check out our latest stories. Visit our news page and read the latest media releases, stories, programs, and initiatives from our company. OCTAPHARMAABOUT USPLASMAPRODUCTSENGAGEMENTNEWSCAREERS Annual Report 2020. 07.04.2021. Press release. Study suggests that 4F-PCC can be used as a substitute for frozen plasma for the treatment of bleeding during cardiac surgery. Results of the FARES study. 30.03.2021. Press release. FDA approvals strengthen Octapharma USA pediatric. Octaplas™, fibryga® receive new product labeling.ANNUAL REPORTS
Annual Report 2020 Remaining strong, resilient and agile. Family-owned since being established in 1983, Octapharma is a global healthcare company reaching hundreds of thousands of patients every year. CAREERS - OCTAPHARMA Learning and development. Each year, we recruit for our corporate trainee programme several young professionals and over 100 colleagues pass through our management training programmes. Octapharma also offers several online learning programmes. Check what we offer at aglobal level.
OCTANATE® - OCTAPHARMA Human plasma-derived coagulation factor VIII concentrate, naturally stabilised with von Willebrand factor (VWF) EUROPEAN AND GERMAN AUTHORITIES APPROVE OCTAGAM® 10% FOR Octapharma announced today that octagam® 10%, a human plasma-derived intravenous immunoglobulin (IVIg), has recently been granted approval in the European Union (EU) as an immunomodulatory therapy for adults with dermatomyositis. Following the EU approval, octagam 10%® received national approval in Germany on May 11, 2 LEADERSHIP - OCTAPHARMA Frederic Marguerre. Shareholders’ Representative, President Octapharma Plasma Inc. USA. Tobias Marguerre. Managing Director, Octapharma Nordic AB OCTAPLAS® / OCTAPLASLG® octaplas® and octaplasLG® are available in 200 ml bags. ALBUNORM® - OCTAPHARMA What can we help you find? About us . About us . Who we areDONOR360
Donor360
OCTAPHARMA SLOVAKIA
Octapharma develops and produces high-quality human proteins from human plasma and human cell lines. Learn more about our products to treat rare diseases and other coagulopathies and bleeding disorders. Check out our latest stories. Visit our news page and read the latest media releases, stories, programs, and initiatives from our company. PRODUCTS - OCTAPHARMA Quality & safety. Octapharma has an international reputation for the safety and quality of its products. We strive for the highest quality throughout the entire production process. Learn all CAREERS - OCTAPHARMA Learning and development. Each year, we recruit for our corporate trainee programme several young professionals and over 100 colleagues pass through our management training programmes. Octapharma also offers several online learning programmes. Check what we offer at aglobal level.
ABOUT US - OCTAPHARMA About us. Our five values -Ownership, Integrity, Leadership, Sustainability and Entrepreneurship- guide our patient-oriented corporate culture. We aspire to embody these values in everything we do. Watch our Vision and Values video. LEARNING & DEVELOPMENT Learning & development. Each year, we recruit several young professionals into our corporate trainee programme and over 100 colleagues pass through our management training programmes. The personal and career development of our employees helps us create a proud and talented workforce dedicated to our vision – to provide new health solutions OCTAPHARMA GROUP DELIVERED STRONG IN 2019 Octapharma Group delivered strong growth in both sales and operating income in 2019. Lachen, Switzerland. 14.02.2020. Press release. Reported revenues of €2.2 billion represent an increase of €417 million (23.2%) on 2018. Operating income of €424 million represents an increase of €78.6 million (22.7%) on 2018.OCTAPLEX®
What can we help you find? About us . About us . Who we areALWAYS ON THE GO
Late into the night, Laurel combs the primary immunodeficiency (PI) social media support groups, answering questions and providing encouragement to patients. Driven by passion and purpose, she is determined to make an impact on the PI community or to simply help a single person cope or understand their diagnosis, treatment andmanagement.
OCTAPLAS® / OCTAPLASLG® octaplas® and octaplasLG® are available in 200 ml bags. ALBUNORM® - OCTAPHARMA What can we help you find? About us . About us . Who we areOCTAPHARMA SLOVAKIA
Octapharma develops and produces high-quality human proteins from human plasma and human cell lines. Learn more about our products to treat rare diseases and other coagulopathies and bleeding disorders. Check out our latest stories. Visit our news page and read the latest media releases, stories, programs, and initiatives from our company. OCTAPHARMAABOUT USPLASMAPRODUCTSENGAGEMENTNEWSCAREERS Annual Report 2020. 07.04.2021. Press release. Study suggests that 4F-PCC can be used as a substitute for frozen plasma for the treatment of bleeding during cardiac surgery. Results of the FARES study. 30.03.2021. Press release. FDA approvals strengthen Octapharma USA pediatric. Octaplas™, fibryga® receive new product labeling.OUR LOCATIONS
62 bis Avenue André Morizet. 92100 Boulogne Billancourt Tel: +33 1 4131 8000. Fax: +33 1 4131 8001. Visit our country website to contact us. Manufacturing sites. France. Octapharma S.A.S. 72 rue du Maréchal Foch. 67380 Lingolsheim Tel: +33 3 8877 6200.ANNUAL REPORTS
Annual Report 2020 Remaining strong, resilient and agile. Family-owned since being established in 1983, Octapharma is a global healthcare company reaching hundreds of thousands of patients every year. CAREERS - OCTAPHARMA Learning and development. Each year, we recruit for our corporate trainee programme several young professionals and over 100 colleagues pass through our management training programmes. Octapharma also offers several online learning programmes. Check what we offer at aglobal level.
OCTANATE® - OCTAPHARMA Human plasma-derived coagulation factor VIII concentrate, naturally stabilised with von Willebrand factor (VWF) OCTAPLAS® / OCTAPLASLG® octaplas® and octaplasLG® are available in 200 ml bags.OCTAPLEX®
What can we help you find? About us . About us . Who we areRHESONATIV®
What can we help you find? About us . About us . Who we areDONOR360
Donor360
OCTAPHARMA SLOVAKIA
Octapharma develops and produces high-quality human proteins from human plasma and human cell lines. Learn more about our products to treat rare diseases and other coagulopathies and bleeding disorders. Check out our latest stories. Visit our news page and read the latest media releases, stories, programs, and initiatives from our company. OCTAPHARMAABOUT USPLASMAPRODUCTSENGAGEMENTNEWSCAREERS Annual Report 2020. 07.04.2021. Press release. Study suggests that 4F-PCC can be used as a substitute for frozen plasma for the treatment of bleeding during cardiac surgery. Results of the FARES study. 30.03.2021. Press release. FDA approvals strengthen Octapharma USA pediatric. Octaplas™, fibryga® receive new product labeling.OUR LOCATIONS
62 bis Avenue André Morizet. 92100 Boulogne Billancourt Tel: +33 1 4131 8000. Fax: +33 1 4131 8001. Visit our country website to contact us. Manufacturing sites. France. Octapharma S.A.S. 72 rue du Maréchal Foch. 67380 Lingolsheim Tel: +33 3 8877 6200.ANNUAL REPORTS
Annual Report 2020 Remaining strong, resilient and agile. Family-owned since being established in 1983, Octapharma is a global healthcare company reaching hundreds of thousands of patients every year. CAREERS - OCTAPHARMA Learning and development. Each year, we recruit for our corporate trainee programme several young professionals and over 100 colleagues pass through our management training programmes. Octapharma also offers several online learning programmes. Check what we offer at aglobal level.
OCTANATE® - OCTAPHARMA Human plasma-derived coagulation factor VIII concentrate, naturally stabilised with von Willebrand factor (VWF) OCTAPLAS® / OCTAPLASLG® octaplas® and octaplasLG® are available in 200 ml bags.OCTAPLEX®
What can we help you find? About us . About us . Who we areRHESONATIV®
What can we help you find? About us . About us . Who we areDONOR360
Donor360
OCTAPHARMA SLOVAKIA
Octapharma develops and produces high-quality human proteins from human plasma and human cell lines. Learn more about our products to treat rare diseases and other coagulopathies and bleeding disorders. Check out our latest stories. Visit our news page and read the latest media releases, stories, programs, and initiatives from our company.OUR LOCATIONS
62 bis Avenue André Morizet. 92100 Boulogne Billancourt Tel: +33 1 4131 8000. Fax: +33 1 4131 8001. Visit our country website to contact us. Manufacturing sites. France. Octapharma S.A.S. 72 rue du Maréchal Foch. 67380 Lingolsheim Tel: +33 3 8877 6200.ANNUAL REPORTS
Annual Report 2020 Remaining strong, resilient and agile. Family-owned since being established in 1983, Octapharma is a global healthcare company reaching hundreds of thousands of patients every year. ABOUT US - OCTAPHARMA About us. Our five values -Ownership, Integrity, Leadership, Sustainability and Entrepreneurship- guide our patient-oriented corporate culture. We aspire to embody these values in everything we do. Watch our Vision and Values video.PLASMA - OCTAPHARMA
Plasma. Many of our life-saving therapies are made from human plasma, with 80% of our plasma coming from company-owned donation centres. In the USA, Octapharma Plasma, Inc. collects, tests and supplies human blood plasma for manufacture into life-saving therapies. Octapharma Plasma, Inc. operates 86 donation centres in 30 states. LEADERSHIP - OCTAPHARMA Frederic Marguerre. Shareholders’ Representative, President Octapharma Plasma Inc. USA. Tobias Marguerre. Managing Director, Octapharma Nordic ABRHESONATIV®
What can we help you find? About us . About us . Who we areALWAYS ON THE GO
Late into the night, Laurel combs the primary immunodeficiency (PI) social media support groups, answering questions and providing encouragement to patients. Driven by passion and purpose, she is determined to make an impact on the PI community or to simply help a single person cope or understand their diagnosis, treatment andmanagement.
ALBUNORM® - OCTAPHARMA What can we help you find? About us . About us . Who we areGAMMANORM®
What can we help you find? About us . About us . Who we are FIBRYGA® RECEIVES EUROPEAN LABEL EXTENSION TO TREAT Octapharma announced today that the human fibrinogen concentrate fibryga ® has received approval for use in treatment of acquired fibrinogen deficiency (AFD) in 15 European countries. The approval extends the market authorisation for fibryga ®, which is already approved for use in patients with congenital fibrinogen deficiency.The addition represents a major milestone for bleeding*
Global
*
*
EN
*
About us
*
Plasma
*
Products
*
Engagement
*
News
*
Careers
OUR COMPANY VALUES
We asked five colleagues from around the globe what the Octapharma values mean to them, and their answers reveal motivating responses.Read them all
NEWS & STORIES
CHECK OUT OUR LATEST STORIES20.05.2020
Press release
FDA APPROVES OCTAPHARMA USA INVESTIGATIONAL NEW DRUG APPLICATION FOR SEVERE COVID-19 PATIENTS Phase 3, multicenter U.S. clinical trial utilizing Octagam® 10% will start immediately to evaluate if high-dose IVIG can stabilize or improve patient clinical status18.05.2020
Press release
FINAL RESULTS FROM THE PROCID STUDY OF EFFICACY Three different dosages of Panzyga® (NewGam)06.04.2020
Corporate news
OCTAPHARMA ACTS TO ACCELERATE DEVELOPMENT OF COVID-19 PLASMA THERAPIES24.03.2020
Corporate news
TO OUR VALUED PATIENTS A messsage from our Chairman and CEO on COVID-19Show more
PATIENT ENGAGEMENT
OCTAPHARMA TAKES AN ACTIVE ROLE IN OUR COMMUNITY We sponsor and support organisations worldwide. Learn how we engage with patientsCAREERS AND JOBS
EXPLORE A NEW WORLD OF OPPORTUNITIES Our global presence offers you a great opportunity to gain international experience. Every employee contributes to the ongoing success of the company. Working with Octapharma WHAT CAN WE HELP YOU FIND? -------------------------*
ABOUT US
*
Who we are
*
------------------------- Diseases & therapies*
------------------------- Research and Development*
-------------------------Our locations
*
PLASMA
*
PRODUCTS
*
Our product portfolio*
------------------------- The production process*
-------------------------Quality and Safety
*
CAREERS
*
Vacancies
*
------------------------- Working with Octapharma*
-------------------------How to apply
*
------------------------- Learning & Development*
ENGAGEMENT
*
Patient Engagement
*
------------------------- International Events*
NEWS
------------------------- 2020 Octapharma AG* Contact
* Data Privacy Statement* Legal Statement
ABOUT COOKIES
To ensure your best user experience, we use cookies and store information on your computer. Some of them are essential to guarantee the best performance of this website. You can select which cookies can be stored, but consider that some functionalities may no longer be available based on your settings. Your data is processed anonymously. You can find general information about processing of personal information in our Data Privacy Statement , where you can change your cookiesettings anytime.
I agreeSettings
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0